EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma

Hua Zheng, Ping Zhou, Jun Wang iD, Yi-Feng Yu, Rui Zhou, Qin Lin, San-Gang Wu iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Hua Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, the First Affiliated Hospital of Xiamen Universi…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess the prognostic effect of plasma Epstein–Barr virus (EBV) DNA load after induction chemotherapy (post IC ‐EBV DNA) on survival outcomes in locoregionally advanced nasopharyngeal carcinoma (LA‐NPC).

Methods

Patients who were diagnosed with LA‐NPC between August 2017 and October 2021 were included. The chi‐squared test, receiver operating characteristic, Kaplan–Meier survival analysis, and Cox proportional hazard model were used for statistical analysis.

Results

We included 172 patients with EBV DNA‐positive LA‐NPC in this study. There were 35.5% ( n = 61) of patients had plasma residual EBV DNA after induction chemotherapy (IC). Patients with higher EBV DNA before IC ( p < 0.001) and advanced nodal stage ( p = 0.031) were significantly related to a higher rate of residual post IC ‐EBV DNA. Patients with detectable post IC ‐EBV DNA had inferior 3‐year locoregional relapse‐free survival (LRFS) (86.7% vs. 96.9%, p = 0.020), distant metastasis‐free survival (DMFS) (76.8% vs. 94.2%, p < 0.001), disease‐free survival (DFS) (68.2% vs. 91.1%, p < 0.001), and overall survival (OS) (87.8% vs. 97.9%, p = 0.044) compared to those with undetectable post IC ‐EBV DNA. The multivariate prognostic analyses showed that detectable post IC ‐EBV DNA was the independent prognostic factor related to LRFS ( p = 0.032), DMFS ( p = 0.010), and DFS ( p = 0.004) than those with undetectable post IC ‐EBV DNA. Pretreatment EBV DNA load had no prognostic effect in the multivariate analyses.

Conclusions

The monitoring of plasma post IC ‐EBV DNA has improved prognostication in LA‐NPC. Our findings suggest that post IC ‐EBV DNA may be a robust indicator to identify the optimal candidate for intensive treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsNasopharyngeal NeoplasmsHumansNasopharyngeal CarcinomaDNA, ViralInduction ChemotherapyHerpesvirus 4, HumanNeoplasm Recurrence, LocalPrognosis

Stichwörter der Autor:innen

Epstein-Barr virusinduction chemotherapynasopharyngeal carcinomaprognosissurvival

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic o…
  • Department of Head and Neck Oncology, Department of Radiation Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

ORCID-Profile: Jun Wang, San-Gang Wu

Zitieren

APA

Zheng, H., Zhou, P., Wang, J., Yu, Y. F., Zhou, R., Lin, Q., & Wu, S. G. (2023). Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.6132

Vancouver

Zheng H, Zhou P, Wang J, Yu YF, Zhou R, Lin Q, et al. Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Cancer Medicine. 2023. doi:10.1002/cam4.6132

BibTeX
@article{Zheng2023,
  author = {Zheng, Hua and Zhou, Ping and Wang, Jun and Yu, Yi-Feng and Zhou, Rui and Lin, Qin and Wu, San-Gang},
  title = {Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6132}
}
Kostenlos starten →